Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Cherry | - |
dc.contributor.author | Do, Kyung-Hyun | - |
dc.contributor.author | Cha, Jaehyung | - |
dc.contributor.author | Song, Jin Woo | - |
dc.contributor.author | Lee, Sang Min | - |
dc.contributor.author | Lee, Ki Yeol | - |
dc.date.accessioned | 2021-08-31T11:31:53Z | - |
dc.date.available | 2021-08-31T11:31:53Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-02 | - |
dc.identifier.issn | 0938-7994 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/57847 | - |
dc.description.abstract | Objectives To determine whether sirolimus has beneficial effects on lymphangioleiomyomatosis (LAM) lung cysts in CT with long-term follow-up (FU) and to investigate whether CT is an appropriate imaging biomarker to monitor and evaluate LAM progression. Methods In this retrospective study, 73 female patients diagnosed with definite LAM between May 2001 and June 2018 were included. Among these, 39 (53.4%) were treated with sirolimus. Quantitative and qualitative CT scoring for lung cysts (CS) were performed and compared between time points (baseline vs. FU at starting sirolimus, baseline vs. last FU, and FU at starting sirolimus vs. last FU for patients treated with sirolimus; baseline vs. last FU for patients without sirolimus). The correlation between CS at each time point and pulmonary function tests (PFTs) at each time point in the patients treated with sirolimus was also investigated. The quantitative and qualitative analyses and PFT results were compared between time points. Results In both quantitative and qualitative analyses, CS significantly increased from baseline to FU after starting sirolimus, and from baseline to last FU (all p < 0.05), whereas there was no significant difference between scores at the start of sirolimus vs. last in the patients treated with sirolimus. After sirolimus treatment, diffusing capacity for carbon monoxide (DLCO) was significantly increased. There were significant correlations between CS at each time point and PFT (correlation coefficient [r], - 0.383-0.935; all p < 0.001). Conclusion Patients with LAM benefited from sirolimus. CT could be a useful imaging biomarker for evaluating and monitoring lung cysts in LAM. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | TUBEROUS SCLEROSIS | - |
dc.subject | GUIDELINES | - |
dc.subject | DECLINE | - |
dc.subject | DISEASE | - |
dc.subject | COMPLEX | - |
dc.title | Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Cherry | - |
dc.contributor.affiliatedAuthor | Lee, Ki Yeol | - |
dc.identifier.doi | 10.1007/s00330-019-06412-4 | - |
dc.identifier.scopusid | 2-s2.0-85071492395 | - |
dc.identifier.wosid | 000511977900007 | - |
dc.identifier.bibliographicCitation | EUROPEAN RADIOLOGY, v.30, no.2, pp.735 - 743 | - |
dc.relation.isPartOf | EUROPEAN RADIOLOGY | - |
dc.citation.title | EUROPEAN RADIOLOGY | - |
dc.citation.volume | 30 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 735 | - |
dc.citation.endPage | 743 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | TUBEROUS SCLEROSIS | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | DECLINE | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordAuthor | Multidetector computed tomography | - |
dc.subject.keywordAuthor | Lymphangioleiomyomatosis | - |
dc.subject.keywordAuthor | Respiratory function tests | - |
dc.subject.keywordAuthor | Sirolimus | - |
dc.subject.keywordAuthor | Tuberous sclerosis complex | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.